Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice

E. Machová, V. Rudajev, H. Smycková, H. Koivisto, H. Tanila, V. Dolezal,

. 2010 ; 38 (1) : 27-35. [pub] 20100104

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

We investigated the functional characteristics of pre- and postsynaptic cholinergic transmission in APPswe/PS1dE9 double transgenic mice at a young age (7-10 weeks) before the onset of amyloid plaque formation and at adult age (5-6 months) at its onset. We compared brain slices from cerebral cortex and hippocampus with amyloid deposits to slices from striatum with no amyloid plaques by 6 months of age. In young transgenic mice we found no impairments of preformed and newly synthesized [(3)H]-ACh release, indicating intact releasing machinery and release turnover, respectively. Adult transgenic mice displayed a significant increase in preformed [(3)H]-ACh release in cortex but a decrease in hippocampus and striatum. The extent of presynaptic muscarinic autoregulation was unchanged. Evoked release of newly synthesized [(3)H]-ACh was significantly reduced in the cortex and hippocampus but unchanged in the striatum. Carbachol-induced G-protein activation in cortical membranes displayed decreased potency but normal efficacy in adult animals and no changes in young animals. These results indicate that functional pre- and postsynaptic cholinergic deficits are not present in APPswe/PS1dE9 transgenic mice before 10 weeks of age, but develop along with beta-amyloid accumulation in the brain.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025320
003      
CZ-PrNML
005      
20130129171147.0
007      
ta
008      
120816e20100104xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.nbd.2009.12.023 $2 doi
035    __
$a (PubMed)20053373
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Machová, Eva. $7 _AN045395 $u Institute of Physiology CAS, Vídenská 1083, 14220 Prague 4, Czech Republic.
245    10
$a Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice / $c E. Machová, V. Rudajev, H. Smycková, H. Koivisto, H. Tanila, V. Dolezal,
520    9_
$a We investigated the functional characteristics of pre- and postsynaptic cholinergic transmission in APPswe/PS1dE9 double transgenic mice at a young age (7-10 weeks) before the onset of amyloid plaque formation and at adult age (5-6 months) at its onset. We compared brain slices from cerebral cortex and hippocampus with amyloid deposits to slices from striatum with no amyloid plaques by 6 months of age. In young transgenic mice we found no impairments of preformed and newly synthesized [(3)H]-ACh release, indicating intact releasing machinery and release turnover, respectively. Adult transgenic mice displayed a significant increase in preformed [(3)H]-ACh release in cortex but a decrease in hippocampus and striatum. The extent of presynaptic muscarinic autoregulation was unchanged. Evoked release of newly synthesized [(3)H]-ACh was significantly reduced in the cortex and hippocampus but unchanged in the striatum. Carbachol-induced G-protein activation in cortical membranes displayed decreased potency but normal efficacy in adult animals and no changes in young animals. These results indicate that functional pre- and postsynaptic cholinergic deficits are not present in APPswe/PS1dE9 transgenic mice before 10 weeks of age, but develop along with beta-amyloid accumulation in the brain.
650    _2
$a acetylcholin $x nedostatek $7 D000109
650    _2
$a věkové faktory $7 D000367
650    _2
$a stárnutí $x metabolismus $7 D000375
650    _2
$a Alzheimerova nemoc $x genetika $x metabolismus $x patofyziologie $7 D000544
650    _2
$a amyloid $x metabolismus $7 D000682
650    _2
$a amyloidový prekurzorový protein beta $x genetika $7 D016564
650    _2
$a zvířata $7 D000818
650    _2
$a mozek $x růst a vývoj $x metabolismus $x patofyziologie $7 D001921
650    _2
$a mozek - chemie $x genetika $7 D001923
650    _2
$a mozková kůra $x růst a vývoj $x metabolismus $x patofyziologie $7 D002540
650    _2
$a cholinergní agonisté $x farmakologie $7 D018679
650    _2
$a cholinergní vlákna $x metabolismus $x patologie $7 D002799
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a down regulace $x genetika $7 D015536
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a proteiny vázající GTP $x účinky léků $x genetika $x metabolismus $7 D019204
650    _2
$a hipokampus $x metabolismus $x patologie $x patofyziologie $7 D006624
650    _2
$a myši $7 D051379
650    _2
$a myši transgenní $7 D008822
650    _2
$a degenerace nervu $x metabolismus $x patologie $7 D009410
650    _2
$a orgánové kultury - kultivační techniky $7 D009924
650    _2
$a presenilin-1 $x genetika $7 D053764
650    _2
$a receptory muskarinové $x metabolismus $7 D011976
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1#
$a Rudajev, Vladimír. $7 jo20211124170
700    1#
$a Smyčková, Helena. $7 _AN070962
700    1_
$a Koivisto, Henna
700    1_
$a Tanila, Heikki
700    1_
$a Doležal, Vladimír, $d 1952 červen 12.- $7 nlk19990073099
773    0_
$w MED00008403 $t Neurobiology of disease $x 1095-953X $g Roč. 38, č. 1 (20100104), s. 27-35
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20053373 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120816 $b ABA008
991    __
$a 20130129171311 $b ABA008
999    __
$a ok $b bmc $g 947362 $s 782666
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 38 $c 1 $d 27-35 $e 20100104 $i 1095-953X $m Neurobiology of disease $n Neurobiol Dis $x MED00008403
LZP    __
$a Pubmed-20120816/10/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...